Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma

International Journal of Surgical Pathology

Volumn 23, Issue 1, 2015, Pages 20-25

  Poswar, Fabiano De Oliveira ^a   Fraga, Carlos Alberto De Carvalho ^a   Gomes, Emisael Stênio Batista ^a   Farias, Lucyana Conceiҫão ^a   Souza, Linton Wallis Figueiredo ^a   Santos, Sérgio Henrique Souza ^a,b   Gomez, Ricardo Santiago ^b   Batista De Paula, Alfredo Maurício ^a   Guimarães, André Luiz Sena ^a  

^a STATE UNIVERSITY OF MONTES CLAROS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Actinic keratosis; Basal cell carcinoma; Matrix metalloproteinase 2; Membrane type matrix metalloproteinase 1; Squamous cell carcinoma

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE 14;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA; STROMA; CANCER GRADING; METABOLISM; MIDDLE AGED; PATHOLOGY; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM GRADING; SKIN NEOPLASMS;

EID: 84920772184     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896914540998     Document Type: Article

References (27)

1. Ridky TW. Nonmelanoma skin cancer. J Am Acad Dermatol. 2007;57:484-501.
2. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42:23-24.
3. Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63:8-18.
4. Kim RH, Armstrong AW. Nonmelanoma skin cancer. Dermatol Clin. 2012;30:125-139.
5. Murphy G, Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med. 2008;29:290-308.
6. Siebuhr AS, Wang J, Karsdal MP, Bay-Jensen AC. Matrix metalloproteinase-dependent turnover of cartilage, synovial membrane, and connective tissue is elevated in rats with collagen induced arthritis. J Transl Med. 2012;10:195.
7. Berry E, Bosonea AM, Wang X, Fernandez-Patron C. Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease. J Vasc Res. 2013;50:52-68.
8. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 1999;189:300-308.
9. Polette M, Nawrocki-Raby B, Gilles C, Clavel C, Birembaut P. Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol. 2004;49:179-186.
10. Sbardella D, Fasciglione GF, Gioia M, et al. Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. Mol Aspects Med. 2012;33:119-208.
11. Fundyler O, Khanna M, Smoller BR. Metalloproteinase-2 expression correlates with aggressiveness of cutaneous squamous cell carcinomas. Mod Pathol. 2004;17:496-502.
12. O'Grady A, Dunne C, O'Kelly P, Murphy GM, Leader M, Kay E. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression. Histopathology. 2007;51:793-804.
13. Hernandez-Perez M, El-hajahmad M, Massaro J, Mahalingam M. Expression of gelatinases (MMP-2, MMP-9) and gelatinase activator (MMP-14) in actinic keratosis and in in situ and invasive squamous cell carcinoma. Am J Dermatopathol. 2012;34:723-728.
14. Orimoto AM, Neto CF, Pimentel ERA, et al. High numbers of human skin cancers express MMP2 and several integrin genes. J Cutan Pathol. 2008;35:285-291.
15. Rah B, Amin H, Yousuf K, et al. A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4. PLoS One. 2012;7:e44039.
16. Basu B, Correa de Sampaio P, Mohammed H, et al. Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain. Int J Biochem Cell Biol. 2012;44:393-403.
17. LeBoit PE, Burg G, Weedon D, Sarasin A. Pathology and Genetics of Skin Tumours. Lyon, France: IARC Press; 2006.
18. Vantuchová Y, Čuřík R. Histological types of basal cell carcinoma. Scripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae. 2006;79:261-270.
19. Saldanha G, Fletcher A, Slater DN. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol. 2003;148:195-202.
20. Broders AC. Squamous-cell epithelioma of the skin: a study of 256 cases. Ann Surg. 1921;73:141-160.
21. Bryne M. Is the invasive front of an oral carcinoma the most important area for prognostication? Oral Dis. 1998;4:70-77.
22. Ramos-Ceballos FI, Ounpraseuth ST, Horn TD. Diagnostic concordance among dermatopathologists using a three-tiered keratinocytic intraepithelial neoplasia grading scheme. J Cutan Pathol. 2008;35:386-391.
23. Souza LR, Fonseca-Silva T, Pereira CS, et al. Immunohistochemical analysis of p53, APE1, hMSH2 and ERCC1 proteins in actinic cheilitis and lip squamous cell carcinoma. Histopathology. 2011;58:352-360.
24. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671-675.
25. Dumas V, Kanitakis J, Charvat S, Euvrard S, Faure M, Claudy A. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas. Anticancer Res. 1999;19:2929-2938.
26. Ting PT, Kasper R, Arlette JP. Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg. 2005;9:10-15.
27. Brouxhon SM, Kyrkanides S, Teng X, et al. Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling. Oncogene. 2014;33:225-235.